Skip to main content

Table 2 NFs mediated GFs and genes delivery systems intended for diabetic complications

From: Nanofiber-based systems intended for diabetes

Type of polymer/material

Incorporated/modified agents

Diameter of nanofiber (nm)

Applied cell type/animal

Main finding

Refs.

HMPA

–a

10−20

Male Sprague−Dawley rats

Increase wound recovery, formation, and blood vessel density

[91]

HBPA

VEGF and FGF-2

–

–

Transplant recipients achieved normoglycemia at a higher rate (78%) than control animals

[92]

Peptide/heparin hybrid

HGF

–

Rat insulinoma β-cell line INS-1/adult male rats

HGF-loaded KLD2R/Hep gel improve β-cell survival and insulin secretion

[93]

PCL

GO and VEGF

10,000

HUVECs

Increase expression of the eNOS gene in the VEGF signaling pathway

[93]

PCL-PEG block copolymers

DNA

–

NIH3T3 cells/mice

More effective than naked DNA in terms of in vivo transfection

[94]

PCL–PEG block copolymer

Small interfering RNA

–

Dermal fibroblasts/female C57BL/6 mice

The delivery system increased the MMP-2 gene-silencing and neo-collagen accumulation at the wound sites

[94]

PCL–PEG diblock copolymer

hEGF

–

HDFs/female C57BL/6 mice

High hEGF expression level, significantly accelerated wound recovery rates at diabetic ulcer site

[95]

PCL and PEG

bFGF and EGF

–

HDF cells/female C57BL/7 mice

Release system increases tissue recovery

[96]

PCL/PEG/PCL triblock copolymer

hEGF

–

Human primary keratinocytes/female C57BL/6 mice

The NFs improved

in vivo wound healing

[97]

PLGA

Vancomycin, gentamicin, and PDGF

371 ± 162 to 655 ± 206

Human fibroblasts/Sprague–Dawley rats

The NFs increased amount of angiogenesis marker (CD31) and accelerated healing in the early stage

[98]

PLAGA

FTY720

–

C57b16/j male mice

The significantly increased the length density of vessels in the moderately diabetic mice

[25]

PLA-PVA

CTGF

2600 ± 1400

3T3 fibroblasts, HaCat keratinocytes, and EA.hy926 endothelial cells

CTGF loaded core–shell NFs improved cell viability, cell proliferation, and cell migration at ulcer site

[23]

PELA

bFGF

783 ± 129

MEF/skin regeneration for diabetic rats with dorsal wounds

The release system improved collagen deposition and ECM remodeling at diabetic ulcer site

[99]

PLGA/CNC composite

Neurotensin

380 ± 28

Round 0.6-cm-diameter full-thickness dermal wounds in mice

The composite NFs promote rapid healing than control groups during 2 week

[100]

Col/HA

VEGF, PDGF, bFGF and EGF

HA: 486 + 151

Col: 534 ± 128

HUVECs/induced diabetic rats

The delivery system accelerated wound closure rate, with elevated collagen deposition and enhanced maturation of vessels

[101]

Eudragit RL/RS 100

Gentamicin and rhEGF

–

Female C57BL/6 mice

The NFs mesh showed

acceptable antibacterial activity and In vivo work induced faster wound healing in dorsal wounds

[102]

PHBV/gelatin methacryloyl

EGF

900 ± 600 to 3500 ± 1800

3T3

fibroblasts, HaCat keratinocytes and EA.hy926 endothelial cells

Promoting keratinocytes, fibroblasts and endothelial cells migration and proliferation and enhanced angiogenesis and in vivo wound healing

[103]

  1. aNot available data in the article
  2. HMPA Heparin mimetic peptide amphiphile, HGF hepatocyte growth factor, PCL polycaprolactone, GO graphene oxide, VEGF vascular endothelial growth factor, HUVEC human umbilical vein endothelial cell, PEG polyethylene glycol, hEGF human epidermal growth factor, HDF human dermal fibroblasts, bFGF basic fibroblast growth factor, PLGA poly lactic-co-glycolide, PDGF platelet-derived growth factor, PLA polylactic acid, PVA poly vinyl alcohol, CTGF connective tissue growth factor, NF nanofiber, PELA poly(ethylene glycol)-poly(dl-lactide), CNC cellulose nanocrystal, MEF mouse embryo fibroblasts, HA hyaluronic acid, Col collagen, PHBV poly 3-hydroxybutyrate-co-3-hydroxyvalerate